CENTOGENE AG is a global leader in the field of genetic diagnostics for hereditary diseases. The international certified (CAP/CLIA/ISO) company is a globally operating biotechnology company with headquarters in Rostock and Berlin and international offices (Dubai, Delhi, Vienna, Boston, etc.).
CENTOGENE is supported by the application of cutting-edge technologies (whole exome/genome sequencing, large organ-specific panels, innovative biomarkers based on high-end mass-spectrometry) and is constantly developing new innovative products in the field of genetics. The analysis of samples from more than 115 countries as well as our it-based (big data, artificial intelligence), molecular knowledge is the basis for the constantly development of the largest mutation database for hereditary diseases(CentoMD®). CENTOGENE is also an strong international partner for multiple renowned pharmaceutical companies in the orphan drug market.